Drug Shortage Report for EDARBI
| Report ID | 245958 |
| Drug Identification Number | 02381389 |
| Brand name | EDARBI |
| Common or Proper name | EDARBI |
| Company Name | BAUSCH HEALTH, CANADA INC. |
| Market Status | MARKETED |
| Active Ingredient(s) | AZILSARTAN MEDOXOMIL |
| Strength(s) | 40MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 28ct |
| ATC code | C09CA |
| ATC description | ANGIOTENSIN II ANTAGONISTS, PLAIN |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | 2025-01-09 |
| Actual start date | |
| Estimated end date | 2025-01-16 |
| Actual end date | 2025-01-13 |
| Shortage status | Resolved |
| Updated date | 2025-01-15 |
| Company comments | Missing/ Waiting on Documents from Supplier |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2150 BOUL. ST-ELZEAR OUEST LAVAL, QUEBEC CANADA H7L 4A8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2025-01-15 | French | Compare |
| v4 | 2025-01-15 | English | Compare |
| v3 | 2025-01-10 | English | Compare |
| v2 | 2024-12-18 | French | Compare |
| v1 | 2024-12-18 | English | Compare |
Showing 1 to 5 of 5